#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12904	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2192	580.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	694	C	680	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12904	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2192	580.9	0	HET	.	.	.	C207T	.	207	207	C	452	452	C	727	C,T	551,143	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23614	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3583	652.8	0	.	n	.	0	T695C	SNP	695	695	T	1130	1130	C	695	C	687	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23614	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3583	652.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2073	2073	G	715	G,A	689,13	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23614	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3583	652.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2406	2406	C	742	C	718	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23614	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3583	652.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2480	2480	A	768	A	754	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23614	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3583	652.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3032	3032	C	729	C	715	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	527	1750	folP	855	855	100.0	folP.l15.c4.ctg.1	1574	109.9	1	SNP	p	R229S	1	.	.	685	687	AGC	997	999	AGC	187;186;183	A;G;C	180;181;175	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	527	1750	folP	855	184	92.93	folP.l15.c4.ctg.2	184	2.5	0	.	p	.	0	M230T	NONSYN	688	690	ATG	45	47	ACG	2;2;2	A;C;G	2;2;2	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	527	1750	folP	855	184	92.93	folP.l15.c4.ctg.2	184	2.5	0	.	p	.	0	A238T	NONSYN	712	714	GCG	69	71	ACC	3;3;3	A;C;C	3;3;3	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	527	1750	folP	855	184	92.93	folP.l15.c4.ctg.2	184	2.5	0	.	p	.	0	S254A	NONSYN	760	762	TCC	117	119	GCT	2;2;3	G;C;T	2;2;3	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	527	1750	folP	855	184	92.93	folP.l15.c4.ctg.2	184	2.5	1	SNP	p	R229S	1	.	.	685	687	AGC	42	44	AGC	2;2;2	A;G;C	2;2;2	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4558	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3589	125.8	1	SNP	p	S91F	1	.	.	271	273	TTC	720	722	TTC	137;138;140	T;T,C;C	134;132,3;136	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4558	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3589	125.8	1	SNP	p	D95G	1	.	.	283	285	GGC	732	734	GGC	144;141;141	G;G,A;C	139;135,3;140	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4558	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3589	125.8	1	SNP	p	G95N	0	.	.	283	285	GGC	732	734	GGC	144;141;141	G;G,A;C	139;135,3;140	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1468	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1329	109.5	1	SNP	p	G45D	0	.	.	133	135	GGC	487	489	GGC	173;172;171	G;G,A;C	168;167,2;168	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	786	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1011	76.5	0	.	n	.	0	A197.	DEL	197	197	A	577	577	A	159	A	152	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4518	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2995	149.6	1	SNP	p	D86N	0	.	.	256	258	GAC	602	604	GAC	186;184;186	G;A;C	182;173;183	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4518	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2995	149.6	1	SNP	p	R87W	0	.	.	259	261	CGT	605	607	CGT	182;180;179	C,A;G;T	175,1;177;172	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4518	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2995	149.6	1	SNP	p	R87I	0	.	.	259	261	CGT	605	607	CGT	182;180;179	C,A;G;T	175,1;177;172	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4518	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2995	149.6	1	SNP	p	S87R	1	.	.	259	261	CGT	605	607	CGT	182;180;179	C,A;G;T	175,1;177;172	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4518	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2995	149.6	1	SNP	p	S88P	0	.	.	262	264	TCC	608	610	TCC	179;181;179	T;C;C	174;176;174	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3466	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2785	123.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1557	1559	GGC	175;176;174	G;G;C,A	170;166;162,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1338	1340	GCC	194;194;193	G,A;C;C,A	189,1;190;188,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1341	1343	ATG	199;194;193	A;T;G,C	195;190;190,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1353	1355	ACC	199;202;201	A,G;C,T;C,G	192,1;199,1;196,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1353	1355	ACC	199;202;201	A,G;C,T;C,G	192,1;199,1;196,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1854	1856	ACC	163;162;162	A;C;C	151;160;159	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1908	1910	GCG	162;158;159	G;C;G	160;157;158	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1908	1910	GCG	162;158;159	G;C;G	160;157;158	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2031	2033	GGT	117;117;116	G;G;T	116;114;113	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2040	2042	AGC	114;114;112	A,G;G;C	106,2;108;105	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3446	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2515	136.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2058	2060	CCG	95;96;92	C;C;G,C	86;91;77,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4944	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3191	153.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1687	1689	CCG	168;169;170	C;C,T;G	157;158,5;159	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2324	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1756	130.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	543	543	C	150	C,G	139,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2560	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1757	144.1	0	.	p	.	0	S175L	NONSYN	523	525	TCA	968	970	TTA	204;202;198	T,G;T,C;A	193,1;197,3;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2560	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1757	144.1	1	SNP	p	G120K	1	.	.	358	360	AAG	803	805	AAG	202;201;201	A,G;A,G,T;G,T	191,2;191,2,1;187,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2560	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1757	144.1	1	SNP	p	A121N	1	.	.	361	363	AAC	806	808	AAC	200;199;204	A,G;A,C;C,A	191,2;191,2;191,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2560	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1757	144.1	1	SNP	p	N121D	0	.	.	361	363	AAC	806	808	AAC	200;199;204	A,G;A,C;C,A	191,2;191,2;191,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8484	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4963	169.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1062	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1223	85.9	1	SNP	p	V57M	1	.	.	169	171	ATG	660	662	ATG	198;199;201	A;T;G	195;194;198	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
